Cargando…

Efficacy and Safety of Longyizhengqi Granule in Treatment of Mild COVID-19 Patients Caused by SARS-CoV-2 Omicron Variant: A Prospective Study

PURPOSE: This study aimed to evaluate the clinical efficacy of Longyizhengqi granule, a traditional Chinese medicine, in patients with mild COVID-19. PATIENTS AND METHODS: We conducted a prospective study including mild COVID-19 participants conducted at Mobile Cabin Hospital in Shanghai, China. Par...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Miao, Shi, Jin, Zhang, Kepei, Hong, Jie, Peng, Xinwei, Tian, Yu, Lu, Wei, Li, Ke, Wang, Zengliang, Li, Feng, Zhang, Zhijie, Mei, Guojiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038206/ https://www.ncbi.nlm.nih.gov/pubmed/36969939 http://dx.doi.org/10.2147/IDR.S389883

Ejemplares similares

Effectiveness and safety of Daixie Decoction granules combined with metformin for the treatment of T2DM patients with obesity: study protocol for a randomized, double-blinded, placebo-controlled, multicentre clinical trial
por: Liu, Zhidong, et al.
Publicado: (2023)

Acupressure in the treatment of patients with mild infection of COVID-19 omicron variant: A prospectively observational study
por: Yang, Qiqi, et al.
Publicado: (2023)

Efficacy and Safety of Jueyin Granules for Patients with Mild-to-Moderate Psoriasis Vulgaris: Protocol for a Multicenter Randomized Placebo-Controlled Trial
por: Li, Su, et al.
Publicado: (2020)

Efficacy and Safety of Huashi Baidu Granules in Treating Patients with SARS-CoV-2 Omicron Variant: A Single-Center Retrospective Cohort Study
por: Chen, Cai-yu, et al.
Publicado: (2023)

Omicron severity: milder but not mild
por: Nealon, Joshua, et al.
Publicado: (2022)

Immunological and metabolic characteristics of the Omicron variants infection
por: Geng, Jiejie, et al.
Publicado: (2023)

Efficacy and safety of Nirmatrelvir/Ritonavir for treating the Omicron variant of COVID-19
por: Qiu, Chaochao, et al.
Publicado: (2023)

Safety and Efficacy of Paxlovid Against Omicron Variants of Coronavirus Disease 2019 in Elderly Patients
por: Weng, Chengzhao, et al.
Publicado: (2023)

Clinical characteristics and risk factors analysis of viral shedding time in mildly symptomatic and asymptomatic patients with SARS-CoV-2 Omicron variant infection in Shanghai
por: Li, Ran, et al.
Publicado: (2023)

Reproduction Number of the Omicron Variant Triples That of the Delta Variant
por: Du, Zhanwei, et al.
Publicado: (2022)

Acupuncture on Obesity: Clinical Evidence and Possible Neuroendocrine Mechanisms
por: Zhang, Kepei, et al.
Publicado: (2018)

Neurological Manifestations of hospitalized patients with mild to moderate infection with SARS-CoV-2 Omicron variant in Shanghai, China
por: Shen, Xiaolei, et al.
Publicado: (2023)

Omicron Booster in Ancestral Strain Vaccinated Mice Augments Protective Immunities Against Both Delta and Omicron Variants
por: Jia, Liqiu, et al.
Publicado: (2022)

Is the Omicron variant of SARS-CoV-2 coming to an end?
por: Zhao, Yingjie, et al.
Publicado: (2022)

The emergence of the Omicron variant
por: Toovey, Oliver T.R., et al.
Publicado: (2022)

Dynamic disease manifestations among individuals infected with SARS-CoV-2 Omicron variant
por: Wang, Peiqin, et al.
Publicado: (2023)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
por: Zang, Jinkai, et al.
Publicado: (2022)

Antiviral Efficacy and Safety of Molnupiravir Against Omicron Variant Infection: A Randomized Controlled Clinical Trial
por: Zou, Rongrong, et al.
Publicado: (2022)

Evidence for a mouse origin of the SARS-CoV-2 Omicron variant
por: Wei, Changshuo, et al.
Publicado: (2021)

Structures of ACE2–SIT1 recognized by Omicron variants of SARS-CoV-2
por: Shen, Yaping, et al.
Publicado: (2022)

Characteristics and implications of Omicron variant associated digestive system infections – Correspondence
por: Shi, Yunjie, et al.
Publicado: (2022)

Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant
por: Zhang, Wei, et al.
Publicado: (2022)

Harringtonine: A more effective antagonist for Omicron variant
por: Hu, Shiling, et al.
Publicado: (2023)

Severity and Vaccine Effectiveness in Patients With the Omicron Variant of COVID-19 in Suzhou: A Retrospective Single-Center Study
por: Cao, Yanmei, et al.
Publicado: (2023)

Analysis of risk factors and short-term prognostic factors of arrhythmia in patients infected with mild/moderate SARS-CoV-2 Omicron variant
por: Yan, Lijie, et al.
Publicado: (2023)

Clinical Characteristics of Mild Patients with Breakthrough Infection of Omicron Variant in China after Relaxing the Dynamic Zero COVID-19 Policy
por: He, Yingyu, et al.
Publicado: (2023)

Treating SARS-CoV-2 Omicron variant infection by molnupiravir for pandemic mitigation and living with the virus: a mathematical modeling study
por: Zheng, Qinyue, et al.
Publicado: (2023)

Heterogeneity of the Omicron variant in Senegal
por: Diédhiou, Cyrille Kouligueul, et al.
Publicado: (2022)

Characterization of mild or asymptomatic patient admitted with Omicron variant of COVID-19 infection in Tibetan mobile cabin hospital China, August—October 2022
por: Shao, Fei, et al.
Publicado: (2023)

Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study
por: Yin, Yun, et al.
Publicado: (2023)

Will New Variants Emerge after Delta and Omicron?
por: Yang, Zhen, et al.
Publicado: (2022)

Investigating the efficacy and safety of mineral smectite granules on wound healing
por: Wang, Jiankun, et al.
Publicado: (2021)

Efficacy and safety of Reyanning mixture in patients infected with SARS-CoV-2 Omicron variant: A prospective, open-label, randomized controlled trial
por: Xu, Xiangru, et al.
Publicado: (2023)

SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters
por: Armando, Federico, et al.
Publicado: (2022)

Comparative analysis of transmission and vaccine effectiveness in Omicron and Delta variant outbreaks in China
por: Li, Kangguo, et al.
Publicado: (2023)

An open, prospective cohort study of VV116 in Chinese participants infected with SARS-CoV-2 omicron variants
por: Shen, Yinzhong, et al.
Publicado: (2022)

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron
por: Zhang, Li, et al.
Publicado: (2021)

Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1
por: Geng, Qibin, et al.
Publicado: (2022)

Importation of SARS-CoV-2 Omicron variant in Beijing, China
por: Li, Fu, et al.
Publicado: (2022)

The efficacy and safety of IBI314 on delta and omicron variant of SARS-CoV-2: First-in-human evidence
por: Sang, Ling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t0afuaousgthbh6j60sovja8if